Article Text

Download PDFPDF

Overview of tobacco use transitions for population health
  1. Andrew Hyland1,
  2. Karin A Kasza1,
  3. Nicolette Borek2,
  4. Heather L Kimmel3,
  5. Kristie A Taylor4,
  6. Wilson M Compton3,
  7. Hannah Day2,
  8. Elisabeth A Donaldson2,
  9. Eva Sharma4,
  10. Gabriella Anic2,
  11. Kathryn C Edwards4,
  12. Michael J Halenar4,
  13. Lynn C Hull2,
  14. Wendy Kissin4,
  15. Jean Limpert2,
  16. Elizabeth L Seaman4,
  17. Maansi Bansal-Travers1,
  18. Lisa D Gardner2,
  19. Hoda T Hammad2,
  20. Cassandra A Stanton4,5
  1. 1 Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
  2. 2 Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
  3. 3 National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA
  4. 4 Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA
  5. 5 Department of Oncology, Georgetown University Medical Center, Washington, DC, USA
  1. Correspondence to Dr Andrew Hyland, Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA; andrew.hyland{at}roswellpark.org

Abstract

The Family Smoking Prevention and Tobacco Control Act provided the US Food and Drug Administration authority to regulate tobacco products using a population health standard. Models have been developed to estimate the population health impacts of tobacco initiation, cessation and relapse transitions. Models should be informed by high-quality, longitudinal data to estimate these constructs. Simulation studies have generated data to predict the impact of various tobacco control interventions, including the influence of regulations on tobacco use behaviours and health. The purpose of this paper is to provide a high-level conceptual overview for understanding tobacco transition behaviours and correlates of these behaviours using data from the Population Assessment of Tobacco and Health (PATH) Study, a US nationally representative longitudinal tobacco study of about 46 000 persons aged 12+ years. The papers that follow in this journal issue build and expand on this conceptual overview using data from the first three waves of the PATH Study. These papers describe use patterns of different tobacco products and their correlates, and can serve as foundations for more in-depth papers that will help the research community better understand the population health impacts and drivers of different tobacco use patterns.

  • surveillance and monitoring
  • electronic nicotine delivery devices
  • non-cigarette tobacco products
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All authors contributed to the conceptual design of the work. AH and KAK drafted the work and all authors critically revised it. All authors approved the work for journal publication and agree to be accountable for all aspects of the work.

  • Funding This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under contract to Westat (Contract No. HHSN271201100027C).

  • Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies.

  • Competing interests WMC reports long-term stock holdings in General Electric Company, 3M Company, and Pfizer Incorporated, unrelated to this manuscript. No financial disclosures were reported by the other authors of this paper.

  • Patient consent for publication Not required.

  • Ethics approval The PATH Study was conducted by Westat and approved by the Westat Institutional Review Board. All respondents ages 18 and older provided informed consent, with youth respondents ages 12-17 providing assent while each one’s parent/legal guardian provided consent.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement There are no data in this work

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.